China, Korea Eye the Latest Multi-Billion Blockbuster Drug Market

  • Samsung and WuXi units ready IPOs to fund big expansion plan
  • Global biologic market on track to top $390 billion in 2020

Bioreactors at Wuxi Biologics's research and development laboratory in Shanghai.

Source: Wuxi Biologics

Inside a factory in eastern China, vats of what might become some of the world’s newest and most sophisticated medicines are brewing.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.